The scientists at BSRC “Alexander Fleming” perform cutting-edge research, aiming to understand molecular mechanisms of complex biological processes in health and disease. We are also committed to contribute to innovation in medicine, by developing novel therapeutic and diagnostic methods, focusing on immunity and inflammation, cancer, and neurodegenerative diseases. To keep our focus on top-notch research, we recruit at all levels with excellence as the sole criterion and we support our researchers by providing state-of-the science infrastructures and a pleasant working environment. FLEMING is a non-profit organization operating under the auspices of the Greek General Secretariat for Research & Technology and is supported by the Greek government and by national, European and international grants.
Novel osteoporosis models. In a study published this week at the Journal of Bone and Mineral Research (DOI: 10.1002/jbmr.2112) the research group of Eleni Douni and colleagues
Fleming researcher Prof. George Kollias has been awarded an Advanced ERC grant, to tackle the role of mesenchymal cells (MC) in intestinal homeostasis during inflammatory and tumorigenic conditions
Seminar 12-03-2014, 13.00. "Tagging nucleotide excision repair in development and disease", George Garinis, Ph.D, Group Leader, Institute of Molecular Biology and Biotechnology, FORTH, Crete.
Announcing the FEBS/EMBO Lecture Course on Nuclear Proteomics that will be held in Kos island, Greece on May 16-22, 2014. More info
Announcing the 2014 European Fly Neurobiology (Neurofly) biennial conference to be held in Heraklion, Crete, Greece on October 5-9, 2014 organised by Fleming researcher Efthimios M.C Skoulakis. Link